New Delhi: The Supreme Court on Friday said that “it will wait for the World Health Organization (WHO) response to Covaxin’s recognition.” And it cannot simply direct the center to decorate people with a covishield which is fully vaccinated with Covaxin against Covid-19.
Judge Dy Chandrachud and BV Nagaratha said it could not play with the lives of people by directing the center to allow people to voluntarily vaccinate with the covishield vaccine even if they have been fully vaccinated with Covaxin.
The top yesterday said that it did not have data about what would affect people and it could not merely direct the center to vaccinate people with covishield.
“We can’t play with the lives of people by directing the center to break.
We don’t have data with us.
We have read in newspapers that Bharat Biotech has submitted an application with the World Health Organization for recognition.
Let’s wait for the response.
We will Do this post-diwali vacation, “said The Apex Court.
Already heard the petition that Covaxin was not approved by WHO and the people here faced difficulties in getting permission to travel abroad during the Covid-19 pandemic.
The Apex Court said that there was also worries that competitors might be in Garb pills trying to take advantage of litigation.
Advocates Kartik Seth, which submitted a request to notify the bench that every day several students and people are willing to go abroad but they are rejected in because Covaxin is not recognized by WHO.
Therefore, individuals who voluntarily at their own costs and risk want to get a covishield even after receiving two doses of Covaxin, may not be prevented to do so, he said.
The request said that at the time of rolling from Covaxin, the government did not make the public aware that it was not approved by WHO.
Bharat Biotech has submitted his request for approval at the end of April 2021 and in May Getting to know many countries do not allow those who are vaccinated with vaccines other than those who register in the list of emergency use, he added.
This urged the court to direct the government that the relevant department released official data and the reason for delay in getting approval to the Covaxin developed by Bharat Biotech.
SC said ‘it will wait for the response to Covaxin’ recognition
